Major but differential decline in the incidence of Staphylococcus aureus bacteraemia in HIV-infected individuals from 1995 to 2007: A nationwide cohort study

HIV Medicine

Volumn 13, Issue 1, 2012, Pages 45-53

  Larsen, M V ^a   Harboe, Z B ^b   Ladelund, S ^a   Skov, R ^b   Gerstoft, J ^c   Pedersen, C ^d   Larsen, C S ^e   Obel, N ^c   Kronborg, G ^a   Benfield, T ^a  

^a Mental Health Services CPH   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Rigshospitalet   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Bacteraemia; Epidemiology; HIV; Injecting drug use; Staphylococcus aureus

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CAUCASIAN; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DENMARK; ETHNICITY; FEMALE; HEPATITIS C VIRUS; HETEROSEXUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; IMMUNE DEFICIENCY; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; POISSON DISTRIBUTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; VIRUS TRANSMISSION;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTEREMIA; DENMARK; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 83855164135     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00937.x     Document Type: Article

References (36)

1. Bearman GM, Wenzel RP. Bacteremias: a leading cause of death. Arch Med Res 2005; 36: 646-659.
2. Tumbarello M, Tacconelli E, Caponera S, Cauda R, Ortona L. The impact of bacteraemia on HIV infection. Nine years experience in a large Italian university hospital. J Infect 1995; 31: 123-131.
3. Fichtenbaum CJ, Dunagan WC, Powderly WG. Bacteremia in hospitalized patients infected with the human immunodeficiency virus: a case-control study of risk factors and outcome. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 51-57.
4. Senthilkumar A, Kumar S, Sheagren JN. Increased incidence of Staphylococcus aureus bacteremia in hospitalized patients with acquired immunodeficiency syndrome. Clin Infect Dis 2001; 33: 1412-1416.
5. Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003; 187: 1452-1459.
6. Craven DE. Staphylococcus aureus colonisation and bacteraemia in persons infected with human immunodeficiency virus: a dynamic interaction with the host. J Chemother 1995; 7(Suppl 3): 19-28.
7. Weinke T, Schiller R, Fehrenbach FJ, Pohle HD. Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1992; 11: 985-989.
8. Nguyen MH, Kauffman CA, Goodman RPet al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann Intern Med 1999; 130: 221-225.
9. Manfredi R, Costigliola P, Ricchi E, Chiodo F. Sepsis-bacteraemia and other infections due to non-opportunistic bacterial pathogens in a consecutive series of 788 patients hospitalized for HIV infection. Clin Ther 1993; 143: 279-290.
10. Nicastri E, Petrosillo N, Viale P, Ippolito G. Catheter-related bloodstream infections in HIV-infected patients. Ann NY Acad Sci 2001; 946: 274-290.
11. Lark RL, Chenoweth C, Saint S, Zemencuk JK, Lipsky BA, Plorde JJ. Four year prospective evaluation of nosocomial bacteremia: epidemiology, microbiology, and patient outcome. Diagn Microbiol Infect Dis 2000; 38: 131-140.
12. Lambotte O, Lucet JC, Fleury L, Joly-Guillou ML, Bouvet E. Nosocomial bacteremia in HIV patients: the role of peripheral venous catheters. Infect Control Hosp Epidemiol 2000; 21: 330-333.
13. Kreisel K, Boyd K, Langenberg P, Roghmann MC. Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagn Microbiol Infect Dis 2006; 55: 179-184.
14. Pedro-Botet ML, Modol JM, Valles Xet al. Changes in bloodstream infections in HIV-positive patients in a university hospital in Spain (1995-1997). Int J Infect Dis 2002; 6: 17-22.
15. Mocroft A, Ledergerber B, Katlama Cet al. Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 2003; 362: 22-29.
16. Benfield T, Espersen F, Frimodt-Moller Net al. Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 2007; 13: 257-263.
17. Statistics Denmark. Population in Denmark, January 1st 2007. Available at. Accessed 1 March 2010.
18. Lohse N, Hansen AB, Jensen-Fangel Set al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis 2005; 37: 338-343.
19. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull 2006; 53: 441-449.
20. Jessen O, Rosendal K, Bulow P, Faber V, Eriksen KR. Changing staphylococci and staphylococcal infections. A ten-year study of bacteria and cases of bacteremia. N Engl J Med 1969; 281: 627-635.
21. Frimodt-Moller N, Espersen F, Skinhoj P, Rosdahl VT. Epidemiology of Staphylococcus aureus bacteremia in Denmark from 1957 to 1990. Clin Microbiol Infect 1997; 3: 297-305.
22. Obel N, Engsig FN, Rasmussen LD, Larsen MV, Omland LH, Sorensen HT. Cohort profile: The Danish HIV Cohort Study. Int J Epidemiol 2009; 38: 1202-1206.
23. Rostgaard K. Methods for stratification of person-time and events - a prerequisite for Poisson regression and SIR estimation. Epidemiol Perspect Innov 2008; 5: 7.
24. Laupland KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008; 198: 336-343.
25. Mocroft A, Phillips AN, Gatell Jet al. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study. Lancet 2007; 370: 407-413.
26. Meynard JL, Guiguet M, Fonquernie Let al. Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics. HIV Med 2003; 4: 127-132.
27. Tumbarello M, Tacconelli E, Donati KGet al. HIV-associated bacteremia: how it has changed in the highly active antiretroviral therapy (HAART) era. J Acquir Immune Defic Syndr 2000; 23: 145-151.
28. Burkey MD, Wilson LE, Moore RD, Lucas GM, Francis J, Gebo KA. The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era. HIV Med 2008; 9: 858-862.
29. Tumbarello M, de Gaetano DK, Tacconelli Eet al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 2002; 50: 375-382.
30. Mathews WC, Caperna JC, Barber REet al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005; 40: 155-160.
31. Liang SH, Lo YC, Lin HHet al. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital. J Microbiol Immunol Infect 2008; 41: 200-208.
32. Popovich KJ, Weinstein RA, Aroutcheva A, Rice T, Hota B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis 2010; 50: 979-987.
33. Edge MD, Rimland D. Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. AIDS 1996; 10: 1635-1639.
34. Wininger DA, Fass RJ. Impact of trimethoprim-sulfamethoxazole prophylaxis on etiology and susceptibilities of pathogens causing human immunodeficiency virus-associated bacteremia. Antimicrob Agents Chemother 2002; 46: 594-597.
35. Styrt BA, Chaisson RE, Moore RD. Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients. AIDS 1997; 11: 1243-1248.
36. Cowan SA, Smith E. Incidence of HIV/AIDS in Denmark, 1990-2005. Ugeskr Laeger 2006; 168: 2247-2252.